Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
about
Pain and spinal cord imaging measures in children with demyelinating diseaseUltrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementUse of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum DisorderEvidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processUltra-high-field MR imaging in multiple sclerosis.Current and new directions in MRI in multiple sclerosis[Ultrahigh field MRI in context of neurological diseases].Advanced MRI and staging of multiple sclerosis lesionsSusceptibility-weighted imaging and quantitative susceptibility mapping in the brainNonconventional MRI and microstructural cerebral changes in multiple sclerosis.Imaging as an Outcome Measure in Multiple Sclerosis.Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosisHigh-field imaging of neurodegenerative diseasesUltrahigh-field MRI in human ischemic stroke--a 7 tesla study.Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysisGradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesionsClinical applications at ultrahigh field (7 T). Where does it make the difference?Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case studyPerivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraineMRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica.Widespread inflammation in CLIPPERS syndrome indicated by autopsy and ultra-high-field 7T MRIVenocentric Lesions: An MRI Marker of MS?Neurological diseases in relation to the blood-brain barrier.Very early MS--insights from MRI.Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010Differential diagnosis of white matter lesions: Nonvascular causes-Part II.Current management of relapsing-remitting multiple sclerosis.Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.Spring cleaning: time to rethink imaging research lines in MS?FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.Insights from Ultrahigh Field Imaging in Multiple Sclerosis.Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.7T MRI in focal epilepsy with unrevealing conventional field strength imaging.Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.Ultra-high-field MR imaging in polymicrogyria and epilepsy
P2860
Q26778244-58047E66-4C69-41AC-963E-380F907D805EQ26796643-197252E4-621D-4D6A-BA19-18955371E651Q28085378-D60DEAAA-EAF2-437B-B2C2-CFB85DBE636AQ29542960-2EA6F251-BEFF-4C32-B6AA-5B81E3EECDFEQ30652464-77E6BBFB-A5DD-4FC5-BEBF-90B7C24A8E4CQ30659431-65250C16-8CB9-4F71-BB6A-21A2C32D64C5Q30759627-69895875-7FF6-43D4-A9B9-388730752E34Q30825494-75FE2A2F-AD13-4E28-B498-972D5DA7D0FEQ30856540-8ECDCC4F-AA37-4E80-8516-DF73054C61D6Q31015218-B836C992-1891-4CD8-93C1-079A76B086D7Q31134617-E3694F9D-25A1-4344-9CEB-B9E00F0748CAQ34203136-3FB32524-0600-4EAC-887B-71DF4E1E3F74Q34252993-FC8172AF-F770-4BC7-80B4-3A7B14C8DAF1Q34304990-8ECF44C8-52D6-4A85-8BCD-239CEDA7777CQ34750423-CA2BA154-4059-4C4D-A992-9A410F244F3BQ35198492-9BD2F1DE-0C29-4450-BC30-33279EF6FCB9Q35575469-4A947F9B-0AA2-45B9-A029-746D6410FD37Q35606720-39651AB1-BA0C-4C15-85C2-FB5D99B63D1BQ35694584-566226E7-94A0-433D-BB7B-61FA0DDFF02DQ36242324-E88A5D50-6F17-40C8-BBBB-E60E5018B4DBQ36557924-3AECB9BB-BBA1-4850-9784-F5486A12BD1BQ36565226-54D7BB02-5C50-4C15-AFDB-3FD7A58DD332Q36599053-AC5DCD7F-1C6B-4E0E-AB6D-916DD0634BE2Q36599879-CC842434-1F10-4F28-90AE-F0B97F7F8B96Q36827200-83242BC7-D3CB-4EAE-BE5F-06C79421F75AQ37030461-7EA86989-7915-4D15-97F5-C94EC39B1D60Q37976564-6224FD62-7ECA-4EFB-8481-6A7DF4FB0A19Q38023710-C963C2B4-F64F-4894-A9B5-2B924990C2F7Q38181064-F7E45ADC-BF52-4B9C-A50C-1556D749C0B7Q38187363-161AE8BD-4C4A-494C-886D-9BD06EFBDC60Q38258818-A873A696-E510-4C48-A5CB-B49384A7D5F2Q38381938-A984A092-27EC-4D34-8CA2-3ECC348A4285Q38737202-201E5FBF-A8AA-4C8B-BE09-A36C7DA18CFAQ38930555-3DD78D86-B491-41AF-B025-DFFDB0465FCEQ39013846-FACDE80D-D396-4B98-B6CB-4FA0E536E832Q39229796-FEB56670-71E7-41F3-A15D-4CE9D2D35B1FQ39937897-EECA7868-6173-49E9-8797-7809AF53A2D2Q40096411-06E2F4FD-0243-4C66-BA8F-C6CF880079F1Q40220046-F7FBD81D-BA73-47CD-9F46-F1983F346D51Q41299267-143668BC-2AF1-4CBC-9299-6D948AD6CA6E
P2860
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@ast
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@en
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@nl
type
label
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@ast
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@en
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@nl
prefLabel
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@ast
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@en
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@nl
P2093
P2860
P1433
P1476
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
@en
P2093
E C Tallantyre
I Donaldson
N Evangelou
P G Morris
P S Morgan
P2860
P304
P356
10.1212/WNL.0B013E31820B7630
P407
P50
P577
2011-02-01T00:00:00Z